Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure.

Avinoam NevlerScott W KeithHarish LavuTheresa P YeoShawnna CannadayCharles J YeoJordan M Winter

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

In all groups surveyed, the probability for a normal life expectancy is the preferred long-term metric in patients with early-staged pancreatic cancer. Renormalization of life expectancy appears to be an important therapy goal for PDA patients and it is advisable to address this topic during clinical discussions.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
papillary thyroid
stem cells
mesenchymal stem cells
young adults
lymph node metastasis
bone marrow
cell therapy
patient reported